Formation Biologics' Series B Round

Formation Biologics raised a round of funding on May 15, 2017. Investors include HBM Healthcare Investments.

Formation Biologics is a clinical stage biopharmaceutical company that engineers protein based therapeutics for treatment of cancer and orphan diseases. The company's lead program is AVID100, an antib…

Articles about Formation Biologics' Series B Round: